Frontiers in Oncology
Construction and internal validation of a risk prediction model for rapid bone loss during aromatase inhibitor therapy

Cohort study of 247 peopleBiomarkers
Multicentre, declared no competing interests
The paper
Wenzhou Medical University
Frontiers in Oncology, 26 Aug 2026


